| Study | Year | Sample time (year.month) | Cases treat/con | Age (years) | Disease (months) | Sex (male/female) | Study design | Outcome measures | Treat group | Con group | Treat group | Con group | Treat group | Con group |
| Zhou [14] | 2019 | 2018.03-2018.12 | 30/30 | | | | | 16/14 | 17/13 | RCT | ①, ③, ④, ⑤ | Zhu [15] | 2012 | 2008.11-2011.05 | 66/66 | | | | | 35/31 | 38/28 | RCT | ②, ③, ④ | Tian [16] | 2020 | 2017.10-2019.01 | 40/40 | 13-17 | 14-17 | 2-11 | 2-12 | 20/20 | 23/17 | RCT | ①, ②, ③ | Lu [17] | 2020 | 2017.01-2019.01 | 50/50 | | | | | 31/19 | 29/21 | RCT | ①, ③ | Du [18] | 2018 | 2016.01-2017.07 | 82/82 | | | | | 37/45 | 34/48 | RCT | ①, ③ | Zhu [19] | 2016 | 2014.04-2015.06 | 35/35 | | | | | 15/20 | 16/19 | RCT | ①, ③, ⑤ | Feng [20] | 2021 | 2017.04-2019.03 | 31/31 | | | | 9 | NP | NP | RCT | ①, ③, ⑤ | Chu [21] | 2020 | 2017.05-2019.06 | 20/20 | | | | | 10/10 | 13/7 | RCT | ②, ③, ⑤ | Yang [22] | 2018 | 2015.03-2016.05 | 43/43 | | | 3-36 | 3-36 | 22/21 | 23/20 | RCT | ①, ③, ④ | Lu [23] | 2020 | 2018.07-2020.07 | 45/45 | | | NP | NP | 29/16 | 28/17 | RCT | ①, ②, ③ | Zhou [24] | 2020 | 2017.07-2018.12 | 68/67 | | | | | 32/36 | 32/35 | RCT | ③, ④ | Melvin [25] | 2006 | 2000.07-2002.12 | 25/22 | 12-18 | 12-18 | NP | NP | 11/14 | 7/15 | RCT | ③, ④ | Wagner et al. [26] | 2003 | 2000.01-2001.06 | 189/187 | 6-17 | 6-17 | 1.5-107.6 | 1.1-119.3 | 81/108 | 103/84 | RCT | ⑤ | Donnelly [27] | 2006 | NP | 103/96 | | | NP | NP | 38/65 | 47/49 | RCT | ⑤ |
|
|